According to NeoGenomics 's latest financial reports the company's current revenue (TTM) is $0.59 B. In 2022 the company made a revenue of $0.50 B an increase over the years 2021 revenue that were of $0.48 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.59 B | 16.07% |
2022 | $0.50 B | 5.24% |
2021 | $0.48 B | 8.97% |
2020 | $0.44 B | 8.71% |
2019 | $0.40 B | 47.73% |
2018 | $0.27 B | 12.21% |
2017 | $0.24 B | 1.04% |
2016 | $0.24 B | 144.57% |
2015 | $99.8 M | 14.62% |
2014 | $87.06 M | 30.99% |
2013 | $66.46 M | 11.02% |
2012 | $59.86 M | 37.68% |
2011 | $43.48 M | 26.51% |
2010 | $34.37 M | 16.63% |
2009 | $29.46 M | 47.23% |
2008 | $20.01 M | 73.97% |
2007 | $11.5 M | 77.65% |
2006 | $6.47 M | 243.5% |
2005 | $1.88 M | 237.83% |
2004 | $0.55 M | 50.84% |
2003 | $0.36 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Quest Diagnostics
DGX | $9.25 B | 1,463.78% | ๐บ๐ธ USA |
LabCorp LH | $12.90 B | 2,080.66% | ๐บ๐ธ USA |
RadNet RDNT | $1.61 B | 173.24% | ๐บ๐ธ USA |
Psychemedics PMD | $22.8 M | -96.15% | ๐บ๐ธ USA |
Enzo Biochem ENZ | $12.8 M | -97.84% | ๐บ๐ธ USA |